Schwazze provided earnings guidance for the fourth quarter of fiscal year 2022. For the period, the company expects revenue annualized run rate is projected to be approximately $220 million to $260 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 USD | -2.33% | -6.67% | -31.11% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.11% | 34.15M | |
+33.13% | 6.03B | |
-31.17% | 3.78B | |
-0.30% | 3.24B | |
-23.56% | 2.73B | |
-10.11% | 2.32B | |
+40.27% | 1.93B | |
+40.53% | 1.5B | |
-25.53% | 1.48B | |
-12.05% | 1.46B |
- Stock Market
- Equities
- SHWZ Stock
- News Medicine Man Technologies, Inc.
- Schwazze Provides Earnings Guidance for the Fourth Quarter of Fiscal Year 2022